FDA Accepts Kabi’s Actemra Biosimilar – Will It Be First?

German Firm Plans Both US And EU Launches In 2023

 
• By Dean Rudge
Race (Panther Media GmbH/Alamy Stock Photo)
Who will get over the line first? • Source: Shutterstock (Panther Media GmbH / Alamy Stock/Alamy Stock Photo)

More from Biosimilars

More from Products